Pharmaceuticals and healthcare-focused private equity (PE) firm Fulcrum Venture India is planning a third fund which could attract as much as INR 700-800 crore. The firm is currently working on registering the new fund with the Securities and Exchange Board of India (Sebi), and the process is expected to be completed by end of the current quarter.